Variable | Category | Hospitalised Population Age < 70 | Oxygen Support | Intensive Therapy | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No | Yes | OR (95% CI) | P>𝛘2 | No | Yes | OR (95% CI) | P>𝛘2 | |||
N | N.Obs | 174 (100.0) | 45 (25.9) | 129 (74.1) | 123 (70.7) | 51 (29.3) | ||||
Ageb | Continuous | 54.3 (10.1) | 51.4 (10.6) | 55.4 (9.8) | 1.04 (1.00–1.07) | 0.250 | 53.1 (10.1) | 57.2 (9.4) | 1.05 (1.01–1.09) | 0.010 |
Gender | Female | 62 (35.6) | 17 (37.8) | 45 (34.9) | 1.00 (−) | – | 46 (37.4) | 16 (31.4) | 1.00 (−) | – |
Male | 112 (64.4) | 28 (62.2) | 84 (65.1) | 1.13 (0.56–2.29) | 0.728 | 77 (62.6) | 35 (68.6) | 1.31 (0.65–2.62) | 0.447 | |
Diabetes | No | 142 (81.6) | 38 (84.4) | 104 (80.6) | 1.00 (−) | – | 106 (86.2) | 36 (70.6) | – | – |
Yes | 32 (18.4) | 7 (15.6) | 25 (19.4) | 1.30 (0.52–3.26) | 0.563 | 17 (13.8) | 15 (29.4) | 0.78 (0.27–2.28) | 0.648 | |
Missing | – | – | – | – | – | – | – | – | – | |
CVD | No | 154 (88.5) | 40 (88.9) | 114 (88.4) | 1.00 (−) | – | 108 (87.8) | 46 (90.2) | – | – |
Yes | 20 (11.5) | 5 (11.1) | 15 (11.6) | 1.05 (0.36–3.08) | 0.925 | 15 (12.2) | 5 (9.8) | 3.50 (2.49–4.90) | < 0.001 | |
Missing | – | – | – | – | – | – | – | – | – | |
Obesity | No | 142 (81.6) | 37 (82.2) | 105 (81.4) | 1.00 (−) | – | 104 (84.6) | 38 (74.5) | 1.00 (−) | |
Yes | 16 (9.2) | 4 (8.9) | 12 (9.3) | 1.06 (0.32–3.48) | 0.927 | 11 (8.9) | 5 (9.8) | 1.24 (0.41–3.81) | 0.706 | |
Missing | 16 (9.2) | 4 (8.9) | 12 (9.3) | – | – | 8 (6.5) | 8 (15.7) | – | – | |
Cancer | No | 164 (94.3) | 40 (88.9) | 124 (96.1) | 1.00 (−) | – | 116 (94.3) | 48 (94.1) | 1.00 (−) | – |
Yes | 10 (5.7) | 5 (11.1) | 5 (3.9) | 0.32 (0.09–1.17) | 0.920 | 7 (5.7) | 3 (5.9) | 1.04 (0.26–4.17) | 0.961 | |
ESRD | No | 171 (98.3) | 45 (100.0) | 126 (97.7) | 1.00 (−) | – | 122 (99.2) | 49 (96.1) | 1.00 (−) | |
Yes | 3 (1.7) | – | 3 (2.3) | 2.52 (0.13–49.70) | 0.178 | 1 (0.8) | 2 (3.9) | 4.98 (0.44–56.18) | 0.177 | |
Missing | – | – | – | – | – | – | – | – | – | |
COPD | No | 165 (94.8) | 44 (97.8) | 121 (93.8) | 1.00 (−) | – | 118 (95.9) | 47 (92.2) | 1.00 (−) | |
Yes | 1 (5.2) | 1 (2.2) | 8 (6.2) | 2.91 (0.35–23.93) | 0.260 | 5 (4.1) | 4 (7.8) | 2.01 (0.52–7.81) | 0.323 | |
Hypertension | No | 115 (66.1) | 33 (73.3) | 82 (63.6) | 1.00 (−) | – | 83 (67.5) | 32 (62.7) | 1.00 (−) | |
Yes | 59 (33.9) | 12 (26.7) | 47 (36.4) | 1.58 (0.74–3.34) | 0.227 | 40 (32.5) | 19 (37.3) | 1.23 (0.62–2.44) | 0.550 | |
Missing | – | – | – | – | – | – | – | – | – | |
Fever | No | 13 (7.5) | 6 (13.3) | 7 (5.4) | 1.00 (−) | – | 8 (6.5) | 5 (9.8) | 1.00 (−) | – |
Yes | 161 (92.5) | 39 (86.7) | 122 (94.6) | 2.68 (0.85–8.46) | 0.100 | 115 (93.5) | 46 (90.2) | 0.64 (0.20–2.06) | 0.462 | |
Cough | No | 59 (33.9) | 20 (44.4) | 39 (30.2) | 1.00 (−) | – | 41 (33.3) | 18 (35.3) | 1.00 (−) | |
Yes | 106 (60.9) | 22 (48.9) | 84 (65.1) | 1.96 (0.96–4.00) | 0.660 | 76 (61.8) | 30 (58.8) | 0.90 (0.45–1.81) | 0.765 | |
Missing | 9 (5.2) | 3 (6.7) | 6 (4.7) | – | – | 6 (4.9) | 3 (5.9) | – | – | |
Asthenia | No | 113 (64.9) | 28 (62.2) | 85 (65.9) | 1.00 (−) | – | 79 (64.2) | 34 (66.7) | 1.00 (−) | |
Yes | 44 (25.3) | 10 (22.2) | 34 (26.4) | 1.12 (0.49–2.55) | 0.787 | 31 (25.2) | 13 (25.5) | 0.97 (0.45–2.09) | 0.947 | |
Missing | 7 (9.8) | 7 (15.6) | 10 (7.8) | – | – | 13 (10.6) | 4 (7.8) | – | – | |
Diarrhea | No | 148 (85.1) | 37 (82.2) | 111 (86.0) | 1.00 (−) | – | 103 (83.7) | 45 (88.2) | 1.00 (−) | |
Yes | 26 (14.9) | 8 (17.8) | 18 (14.0) | 0.75 (0.30–1.87) | 0.542 | 20 (16.3) | 6 (11.8) | 0.69 (0.26–1.82) | 0.440 | |
Missing | – | – | – | – | – | – | – | – | – | |
Dyspnea | No | 87 (50.0) | 29 (64.4) | 58 (45.0) | 1.00 (−) | – | 66 (53.7) | 21 (41.2) | 1.00 (−) | |
Yes | 87 (50.0) | 16 (35.6) | 71 (55.0) | 2.22 (1.10–4.48) | 0.240 | 57 (46.3) | 30 (58.8) | 1.65 (0.85–3.20) | 0.133 | |
Missing | – | – | – | – | – | – | – | – | – | |
Procalcitonin ng/mL | < 0.2 | 131 (75.3) | 40 (88.9) | 91 (70.5) | 1.00 (−) | 98 (79.7) | 33 (64.7) | 1.00 (−) | ||
≥0.2 | 43 (24.7) | 5 (11.1) | 38 (29.5) | 3.34 (1.22–9.12) | < 0.01 | 25 (20.3) | 18 (35.3) | 2.14 (1.04–4.41) | 0.410 | |
Missing | – | – | – | – | – | – | – | – | – | |
LDH U/L | Low | 44 (25.3) | 26 (57.8) | 18 (14.0) | 1.00 (−) | – | 75 (61.0) | 11 (21.6) | 1.00 (−) | – |
High | 130 (74.7) | 19 (42.2) | 111 (86.0) | 8.44 (3.89–18.29) | < 0.001 | 48 (39.0) | 40 (78.4) | 5.68 (2.66–12.14) | < 0.001 | |
Missing | – | – | – | – | – | – | – | – | – | |
MDW | Low | 57 (32.8) | 26 (57.8) | 31 (24.0) | 1.00 (−) | – | 64 (52.0) | 12 (23.5) | 1.00 (−) | – |
High | 117 (67.2) | 19 (42.2) | 98 (76.0) | 4.33 (2.11–8.85) | < 0.001 | 59 (48.0) | 39 (76.5) | 3.53 (1.69–7.37) | < 0.001 | |
Missing | – | – | – | – | – | – | – | – | – | |
Saturation % | High | 91 (52.3) | 40 (88.9) | 51 (39.5) | 1.00 (−) | 103 (83.7) | 26 (51.0) | 1.00 (−) | ||
Low | 81 (47.7) | 4 (8.9) | 77 (59.7) | 15.10 (5.09–44.77) | < 0.001 | 19 (15.4) | 24 (47.1) | 5.00 (2.39–10.49) | < 0.001 | |
Missing | – | 1 (2.2) | 1 (0.8) | – | – | 1 (0.8) | 1 (2.0) | – | – | |
D-dimer mg/L | Low | 61 (35.1) | 18 (40.0) | 43 (33.3) | 1.00 (−) | – | 119 (96.7) | 45 (88.2) | 1.00 (−) | – |
High | 113 (64.9) | 27 (60.0) | 86 (66.7) | 1.33 (0.66–2.68) | 0.423 | 4 (3.3) | 6 (11.8) | 3.97 (1.07–14.71) | 0.380 | |
Missing | – | – | – | – | – | – | – | – | – | |
Prothrombin Time % | High | 77 (44.3) | 22 (48.9) | 55 (42.6) | 1.00 (−) | 74 (60.2) | 24 (47.1) | 1.00 (−) | ||
Low | 97 (55.7) | 23 (51.1) | 74 (57.4) | 1.29 (0.65–2.54) | 0.468 | 49 (39.8) | 27 (52.9) | 1.70 (0.88–3.28) | 0.114 | |
Missing | – | 0 (0.0) | 0 (0.0) | – | – | 0 (0.0) | 0 (0.0) | – | – | |
CRP mg/L | Low | 65 (37.4) | 28 (62.2) | 37 (28.7) | 1.00 (−) | – | 76 (61.8) | 17 (33.3) | 1.00 (−) | – |
High | 109 (62.6) | 17 (37.8) | 92 (71.3) | 4.10 (2.01–8.36) | < 0.001 | 47 (38.2) | 34 (66.7) | 3.23 (1.63–6.43) | < 0.001 | |
Lymphocytes x103μL | High | 56 (32.2) | 25 (55.6) | 31 (24.0) | 1.00 (−) | – | 90 (73.2) | 26 (51.0) | 1.00 (−) | |
Low | 118 (67.8) | 20 (44.4) | 98 (76.0) | 3.95 (1.94–8.06) | < 0.001 | 33 (26.8) | 25 (49.0) | 2.62 (1.33–5.17) | < 0.01 |